Inflammatory Markers and Diabetic Retinopathy in Type 1 Diabetes

Authors:

Abstract
This was a cross-sectional prospective study comprised of subjects with type 1 diabetes (n = 154) matched by age and sex with nondiabetic control subjects in a 3:1 ratio. Eligible subjects (control subjects and type 1 diabetic patients) were between the ages of 14 and 42 years. Test subjects had type 1 diabetes for >5 years. Subjects were excluded if they had a blood pressure >140/90 mmHg, were tobacco users, were on medications known to affect CRP (ACE inhibitors, hydroxymethylglutaryl CoA reductase inhibitors, nonsteroidal anti-inflammatory agents, and aspirin), had other known concomitant illnesses, or were pregnant. Written informed consent was obtained from willing participants using institutional review board-approved consent forms and Health Insurance Portability and Accountability Act-compliant authorization forms.

This publication has 9 references indexed in Scilit: